Bioponic Phytoceuticals, Inc. (OTC Bulletin Board: BPYT - News; "Bioponic" or "the Company") today announced that Dr. Barbara Anne Nabrit-Stephens, MD, MBA, FAAP has joined the Company's Scientific Advisory Board. Dr. Nabrit-Stephens is a board-certified pediatrician with over 30 years of health care experience. As a scientific advisor, Dr. Nabrit-Stephens will help validate and formulate Bioponic's strategies to market its all-natural therapeutic products, including Curecumin(TM) and Curmisinin(TM).

"We are honored to welcome Dr. Nabrit-Stephens to our Scientific Advisory Board. Dr. Nabrit-Stephens' in-depth experience as both a clinician and health care administrator is a true asset to our organization," said Steven M. Schorr, Chairman and CEO of Bioponic. "Testing and research programs for Alzheimer's applications for Curecumin(TM) and distribution of Curmisinin(TM) to treat the deadly cerebra malaria, which kills over 2 million children in Sub-Saharan Africa, are the first projects Dr. Nabrit-Stephens will be involved in. She is also ideally suited to advise us on our newest product line, Gentle Mother, specifically for the needs of newborns and infants."

Dr. Nabrit-Stephens said, "I've always been attracted to those companies who focus on providing pro-active healthcare solutions, especially to those populations at-risk. Bioponic's work in bringing all-natural treatments to control devastating malaria in Africa is very impressive. I believe Bioponic's Bioresonant formulations could potentially represent a breakthrough in the treatment of epidemic disease. I am intrigued to discover more about the Company and their product lines, and look forward to our ongoing collaboration."

In a recent study entitled, "Curcumin prevents and reverses murine cardiac hypertrophy," published in the February 2008 edition of the Journal of Clinical Investigation, researchers found that when the herb was given orally to a variety of mouse models with enlarged hearts (hypertrophy), it can prevent and reverse hypertrophy, restore heart function and reduce scar formation.

"Whether you are young or old; male or female; the larger your heart is, the higher your risk is for developing heart attacks or heart failure in the future," explains Dr. Liu, a cardiologist in the Peter Munk Cardiac Centre at the Canadian Institutes of Health Research - Institute of Circulatory and Respiratory Health. If clinical trials of curcumin support initial findings of heart enlargement prevention, it may offer hope for millions of patients with heart enlargement. Dr. Liu, who holds the Heart and Stroke Foundation's Polo Chair Professor in Medicine and Physiology at the University of Toronto, says that curcumin may be a safe and effective means of preventing heart failure in the future. This study was funded by the Heart and Stroke Foundation and the Canadian Institutes of Health Research.

"Curcumin has been the subject of extensive research over the past few years, and has been shown to protect the liver, inhibit tumors, reduce inflammation and prevent the formation of the amyloid beta plaques which cause Alzheimer's Disease. We are encouraged by yet another study that suggests the versatile curcumin may lower heart failure risk," said Steven M. Schorr, Chairman and CEO of Bioponic. "More than 5 million Americans are living with heart failure, and 550,000 new cases are diagnosed each year, according to the American Heart Association. The potential that our Curecumin(TM) product (http://www.curecumin.com) could provide a viable treatment strategy for those at risk for heart failure is very exciting. If proven effective, we may have an efficacious, cost effective, natural treatment for heart failure sufferers."

Bioponic Phytoceuticals, Inc. ("Bioponic" or "the Company") (OTC: BPYT)

announced today that Nature's Best, the largest privately-owned wholesaler-distributor of health and natural food products in the Natural Products industry, has been named the Company's Master Distributor covering the Western United States. Effective April 1, 2008, Nature's Best is responsible for distributing five of Bioponic's most popular consumer brands to approximately 1,000 health food stores and natural product retailers in the Western United States.

Bioponic's all natural, organic health and wellness products scheduled for distribution are: Hawaiian Healing Mist™, O-Spray™, Throat Note™, Gentle Mother™ and Noni Healing Tonic, representing a total of 11 products. Individual product descriptions may be found by visiting Bioponic's website at http://www.bioponic.com.

“We are thrilled to be represented by Nature's Best. Their well-earned reputation of bringing the finest in certified organic, natural and specialty products to retail markets is a boon for our company. This master distributorship is a unique opportunity to build upon the local and online retail success of our core skin care and wellness product lines, as well as promote our latest all-natural lines like Gentle Mother,” said Steven M. Schorr, Chairman & CEO of Bioponic.

Schorr concluded, “We anticipate solid representation across retail shelves in the Western United States, including key markets with highly favorable demographics in the state of California, will help us ramp up product revenues throughout 2008.”  

HULIQ.com Public News Organization Posted in: Health Lung Cancer Lung Cancer Treatment

Bioponic Phytoceuticals has announced that its Curecumin (a Bioresonant Phytotherapeutic form of Turmeric containing curcumin in a liquid nasal delivery system) may be an important treatment for Lung Cancer.

In a recent study published in Science Direct, “Induction of Apoptosis in Human Lung Cancer Cells by Curcumin,” conducted at the Department of Medicine, Pediatrics and Family and Preventive Medicine, School of Medicine, University of California, San Diego, scientists concluded, “Curcumin, a phenolic compound from the rhizome of the plant Curcuma longa has anti-inflammatory, antioxidant and anti-cancer activities…

This study investigated the cellular and molecular changes induced by curcumin leading to the induction of apoptosis in human lung cancer cell lines — A549 and H1299… Curcumin inhibited the growth of both the cell lines in a concentration dependent manner… Curcumin induced apoptosis in both the lung cancer cell lines.”

“We are particularly interested in the potential of our Curecumin(TM) product to provide a viable treatment strategy for those with lung cancer. Especially, because the liquid form of Curecumin, in a nasal delivery system, will send the formula directly to the lungs. If proven effective, we may have an efficacious, cost effective, natural treatment for lung cancer sufferers.” said Steven M. Schorr, Chairman & CEO — Bioponic Phytoceuticals, Inc.

This nasal spray created for dehydrated travelers contains turmeric root, spearmint and pure filtered water. The herbal remedy also claims to clear sinuses, protect against sore throat, and relieve congestion. And since it's only one fluid ounce, it's TSA approved for carry-on.

We achieved a record breaking month of sales in January, primarily from continued success of our Flight Spray product. We are also gaining market traction for our latest product release, an all-natural solution for baby care marketed under the Gentle Mother(TM) line," said Steven M. Schorr, Chairman & CEO of Bioponic. "Bioponic is now focused on establishing distribution relationships that will greatly expand the availability of multiple product lines, including O-Spray(TM), Throat Note(TM), Gentle Mother(TM), Hawaiian Healing Mist, and Noni Healing Tonic for placement into national health food stores and natural products retailers. Our goal is take our core product lines and position them for exponential sales growth, much like Flight Spray achieved when it gained a presence in over 1,000 points of distribution."

"We have secured an agreement with a leading wholesaler-distributor in the Natural Food industry to bring five of our all natural health and wellness product lines, representing 11 products, into 1,000 retail stores in the Western U.S. We expect the results of this distributorship, and other marketing channels, will lead to aggressive total revenue growth for Bioponic in 2008," said Schorr.

Every year at about this time, the great-gifts-for-travelers lists come out. And every year, I dream of being able to justify splurging on one or more of those items--the Bose noise-cancellation headphones, the cashmere blankie, the luscious leather satchel or maybe a year's worth of airport lounge access.

But I’m happy to say that it's still possible to treat yourself (and your traveling friends, colleagues and loved ones) to wonderful swag that’s actually affordable. Here are some of my favorites, all for less than $25:

Flight Spray. You may be taken aback if someone gives you nasal spray as a gift, but for road warriors who've experienced the unpleasant consequences of dehydration, it's actually quite thoughtful. The spray not only relieves symptoms but can also help prevent colds--and it soothes if you’re flying when you already have a cold or congestion. This spray is all-natural, made from turmeric root (an anti-bacterial, anti-fungal agent), spearmint (a natural antiseptic) and purified water. The 1-ounce spray bottle is small enough to pass TSA rules about onboard liquids. $14.85 from Magellans.com.

  --  This month, we launched Curemisinin(TM), an all-natural
        artemisinin-based treatment for malaria. Alternative anti-malaria
        medicines are in dire need in places like Africa, where every 30
        seconds a child dies of the disease. According to the World Health
        Organization (WHO), "The inappropriate use of anti-malarial drugs in
        the past century contributed to widespread resistance in the malaria
        parasite to drugs such as chloroquine, leading to rising rates of
        sickness and death. Over the past decade, a new group of
        antimalarials-- known as artemisinin-based combination
        therapies -- has brought new hope in the fight against malaria."
        (http://www.who.int/features/factfiles/malaria/en/index.html)
    --  Representatives from the American Friends of Guinea began distributing
        Curemisinin to clinics in Conakry, the capital city of Guinea, Africa.
        These human clinical trials will record the efficacy of Curemisinin,
        an important step toward partnering with WHO and other organizations
        that can aide Bioponic in bringing Curemisinin into countries where it
        is needed most.
    --  Our flagship product Flight Spray® is on the heels of a mass-market
        launch into national retail outlets, including major health food
        chains, top-name pharmacies and drug stores, beginning in the first
        quarter of 2008.
    --  Our Master Broker for the Western U.S., Active Sales and Marketing of
        Southern California, will expand our retail channels for six of our
        core product lines to 1,000 or more of the nation's top health food
        stores in the Western region. We anticipate this agreement can add
        $1.5 Million in sales to Bioponic in 2008.
    --  This month also marked the launch of our first product suite geared
        specifically for newborns and infants called Gentle Mother(TM). Gentle
        Mother, a suite of five products that treat common ailments of babies,
        is available for purchase online and will be rolled out to 1,000 or
        more national retail chains beginning in 2008.
    --  Entered into a $500,000 exclusive production and sales agreement with
        Malie, Inc. of Kauai, Hawaii to manufacture Malie's new Facial Tonic
        product line using Bioponic's proprietary ingredients and
        formulations.
    --  Received an initial order from Singapore-based Muji Global Sourcing
        Pte. Ltd. ("Muji"), who will be selling several Bioponic product lines
        throughout its established territories in Asia.
    --  Developed Curecumin(TM), a Bioresonant Phytotherapeutic(TM) formula
        designed to treat Alzheimer's Disease and the five leading forms of
        cancer (breast, colon, lung, prostate and skin cancers)
    --  Continue to develop our portfolio of intellectual properties with the
        acquisition of trademarks for our branded products and patent pending
        status for our Bioresonant Phytotherapeutic technology.

"Bioponic"), an innovative provider of natural products and patented technology serving the Complementary Alternative Medicine (CAM) and nutraceutical markets, announced the launch of its first product suite geared specifically for newborns and infants called "Gentle Mother(TM)". Gentle Mother is comprised of five, all natural herbal remedies based on the Company's proprietary Bioresonant Phytotherapeutic(TM) formulations with easy-to-use, liquid spray delivery systems. Each product is a gentle water-based formula designed to soothe and treat common, recurring ailments such as diaper rash, teething, nasal congestion, as well as aide in digestion and sleep.

"Many parents are turning towards all natural baby formulations to avoid additives and unwanted preservatives that may cause side effects or can be detrimental to their children's health, especially over extended periods of use. Consumers are more health conscious, environmentally aware and receptive to alternative remedies than ever before. Demand for natural baby products is dramatically on the rise, and a number of the world's leading brands and grocers are clearing shelf space for 'green' baby product lines. For instance, one leading food chain has tripled the space allotted to natural baby products in just the last five years," said Steven M. Schorr, chairman and CEO of Bioponic.

Gentle Mother is currently available for purchase at http://www.bioponic.com and will soon be available in leading health food stores. According to Schorr, "We are very enthusiastic to begin marketing Gentle Mother worldwide, and in early 2008 we plan to make the entire suite available in over 1,000 health food stores. We have the distribution agreements in place to take several of our products to a national scale, and Gentle Mother is a very promising addition in our product line-up for 2008."

About Bioponic Phytoceuticals

Bioponic Phytoceuticals is engaged in the development, production and distribution of Bioresonant Phytotherapeutic(TM) products. The Company has developed several branded product lines, including the nasal spray: Flight Spray® (http://www.flightspray.com); Curecumin(TM) (a treatment for Alzheimer's Disease); Curemisinin(TM) (a treatment for malaria); O-Spray(TM) (scented nasal sprays); Throat Note(TM) (formulated for professional speakers and singers, great for everyone!) and the effective natural skincare product Hawaiian Healing Mist(TM). Bioponic is focused on the production of natural products that are used to promote health and well being.

All statements other than statements of historical fact included in this press release are "forward-looking statements" within the meaning of federal securities laws. Such forward-looking statements are subject to a number of risks and uncertainties, some of which are beyond the Company's control.

CONTACT: Steven M. Schorr, CEO, Bioponic Phytoceuticals, +1-808-876-1711, 

A new malaria treatment [Curemisinin] is being disseminated free-of-charge in clinics located in the Guinean capital Conakry, Bioponic Phytoceuticals announced.

Curemisinin (TM), an all-natural anti-malaria product that is based on three proven effective anti-malaria herbs: Artemesia, Turmeric and Cinchona Bark, is launched by Bioponic Phytoceuticals.

Bioponic is focused on the production of natural products that are used to promote health and well-being and its binary product comprises a nasal spray [Curemisinin A] with an oral spray [Curemisinin B] to treat malaria in the quickest, most effective manner.

The efficacy of Curemisinin will be recorded, and provide valuable data over the next several weeks on the product's ability to treat malaria in humans.

The Chairman and CEO of Bioponic, Steven Schorr said, "Curemisinin's use of a nasal delivery system allows the bioresonant liquid remedy to be delivered directly to the brain via the nasal membrane. This may have a significant impact on cerebral malaria, a condition primarily affecting children, who die within 24 to 7 hours without treatment.

Biponic not only hopes to stop the track of cerebral malaria, but potentially help bring down the cost of treatment and increase the efficacy of treatments for all types of malaria, especially resistant strains of the disease."

Caused by a blood parasite transmitted by mosquitoes, malaria has become the number one killer disease in sub-Saharan Africa. Every year, malaria kills more than a million people worldwide, majority of its victims being African children.

As evolving pathogens develop widespread resistance to over-prescribed antibiotics, anti-virals and antimalarial drugs, the use of natural medicines is being recommended for their proven efficacy in the treatment of vast malaria problem.

Bioponic Phytoceuticals, Inc. (BPYT) announced the launch of Curemisinin(TM), an all-natural anti-malaria product that is based on three proven effective anti-malaria herbs (Artemesia, Turmeric and Cinchona Bark) extracted through the Company's proprietary extraction/distillation technologies. This binary product comprises a nasal spray (Curemisinin A) with an oral spray (Curemisinin B) to treat malaria.

ABOUT KNOBIAS: Knobias is a premier financial information provider of trading and investing data covering all U.S. equities for investors and security professionals. Knobias is best described by its three major components: Real-time desktop applications providing quotes, charts, level 2, analysis etc.; Knobias RAiDAR providing thousands of real-time news stories, alerts and documents daily; Knobias fundamentals providing a comprehensive database of fundamental research information.

"Bioponic"), an innovative provider of natural products and patented technology serving the Complementary Alternative Medicine (CAM) and nutraceutical markets, announced today the launch of Curemisinin(TM), an all-natural anti-malaria product that is based on three proven effective anti-malaria herbs: Artemesia, Turmeric and Cinchona Bark, uniquely extracted through the Company's proprietary extraction/distillation technologies. This binary product comprises a nasal spray (Curemisinin A) with an oral spray (Curemisinin B) to treat malaria in the quickest, most effective manner.

Malaria is a disease caused by a blood parasite transmitted by mosquitoes, and the number one killer in sub-Saharan Africa, killing more than a million people worldwide, every year. The majority of those who die from malaria are African children, according to the Centers for Disease Control. Through Bioponic's international alliance with Hyperdynamics Corp, Curemisinin is currently being disseminated free-of-charge in clinics located in the capital city of Guinea, Africa. The efficacy of Bioponic's Curemisinin will be recorded, and provide valuable data over the next several weeks on the product's ability to treat malaria in humans.

Bioponic's Chairman and CEO Steven M. Schorr remarked, "Curemisinin's use of a nasal delivery system allows the bioresonant liquid remedy to be delivered directly to the brain via the nasal membrane. This may have a significant impact on Cerebral Malaria, a condition primarily affecting children, who die within 24 to 72 hours without treatment. Bioponic not only hopes to stop the track of cerebral malaria, but potentially help bring down the cost of treatment and increase the efficacy of treatments for all types of malaria, especially resistant strains of the disease."

About Bioponic Phytoceuticals

Bioponic Phytoceuticals is engaged in the development, production and distribution of Bioresonant Phytotherapeutic(TM) products. The Company has developed several branded product lines, including the nasal spray: Flight Spray® (http://www.flightspray.com); Curecumin(TM) (a treatment for Alzheimer's Disease); O-Spray(TM) (scented nasal sprays); Throat Note(TM) (formulated for professional speakers and singers, great for everyone!) and the effective natural skincare product Hawaiian Healing Mist(TM). Bioponic is focused on the production of natural products that are used to promote health and well-being.

All statements other than statements of historical fact included in this press release are "forward-looking statements" within the meaning of federal securities laws. Such forward-looking statements are subject to a number of risks and uncertainties, some of which are beyond the Company's control.

CONTACT: Steven M. Schorr, CEO, Bioponic Phytoceuticals, +1-808-876-1711, info@bioponic.com or Geoffrey Eiten, Investor Relations, OTC Financial Network, 781-444-6100x613, geiten@otcfn.com, http://www.otcfn.com/bpyt.

Bioponic Phytoceuticals, Inc. (BPYT) is preparing to launch a national roll-out of its nasal hydration product Flight Spray(R) to mass market retailers and top-name pharmacy and drug store chains beginning in the first quarter of 2008. Flight Spray is the first all-natural nasal hydration spray formulated especially for airline travel. The 1oz bottle of Flight spray is an approved on-board liquid, which eliminates consumer concerns over traveling regulations.

Flight Spray is currently sold in travel-related retail stores and via web sites such as Magellens.com, TravelSmith.com and Drugstore.com, and on the Company-owned FlightSpray.com.